GLUE - Balance Sheet - Monte Rosa Therapeutics, Inc.

Current Liabilities	157 M
Accounts Payable	17.2 M
Short-Term Debt	3.71 M
Other Current Liabilities	136 M
Non-Current Liabilities	58.8 M
Long-Term Debt	0
Other Non-Current Liabilities	58.8 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	224.3	128.1	54.9	346.1	41.7	6.0
Short Term Investments	147.9	104.3	207.9	0	0	0
Receivables	0.2	0.5	7.7	0	0	0
Inventory	0	0	1.0	0	0	0
Other Current Assets	5.1	3.3	5.4	5.2	1.8	3.8
Total Current Assets	377.4	236.2	275.9	348.7	43.6	9.8
PP&E	56.3	62.6	61.9	12.3	4.6	1.3
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	4.3	5.3	1.2	0
Other Long Term Assets	5.0	4.9	0.3	0	0	0
Other Assets	0	0	0	0	0	0
Total Assets	438.7	303.8	342.4	366.3	49.4	11.1
LIABILITIES
Accounts Payable	17.2	11.2	7.9	6.6	7.1	3.2
Short Term Debt	3.7	3.2	6.3	0	0	0.8
Other Current Liabilities	18.8	14.6	11.5	10.1	22.2	0.3
Total Current Liabilities	156.9	46.6	25.6	16.6	29.3	4.3
Long Term Debt	0	42.9	43.9	0	67.8	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	42.7	2.7	1.5	2.2	0	0
Total Liabilities	215.8	124.5	71.0	18.8	98.1	23.2
EQUITY
Common Stock	6 K	5 K	5 K	5 K	1 K	50 K
Retained Earnings	(438.6)	(365.9)	(230.5)	(122.0)	(48.1)	(12.2)
Other Accumulative Comprehensive Income/Loss	(3.4)	(2.7)	(1.8)	(2.0)	(1.1)	69 K
Total Equity	222.9	179.2	271.4	347.5	(48.7)	(12.1)
Total Liabilities and Equity	438.7	303.8	342.4	366.3	49.4	11.1
SHARES OUTSTANDING
Common Shares Outstanding	73.9	51.4	47.2	46.5	44.0	44.0

Free